Protein Microarray Market Report 2025

This protein microarray market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The protein microarray market size has grown strongly in recent years. It will grow from $3.92 billion in 2024 to $4.3 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increase in demand for personalized medicine, rise in prevalence of chronic diseases, growth in the biotechnology sector, rise in awareness of early disease detection, and growth in drug discovery and development activities.

The protein microarray market size is expected to see strong growth in the next few years. It will grow to $6.13 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising interest in biomarker discovery, rising adoption of high throughput screening methods, increasing focus on early disease detection, increasing awareness of proteomics technology, and rising prevalence of genetic disorders. Major trends in the forecast period include development of high throughput systems, development of novel substrates for reduced noise, advancements in multiplexing capabilities, adoption of microfluidics for automation, and advancements in miniaturization for high density arrays.

The growing adoption of genomics is anticipated to drive the expansion of the protein microarray market. Genomics, which involves studying an organism's entire set of genetic material - including its structure, function, and evolutionary changes - benefits from advances in technology, decreased sequencing costs, and the potential for personalized medical treatments. Genomics supports protein microarrays by offering detailed genetic information that helps identify and analyze proteins, their interactions, and functions, thus enabling more targeted and high-throughput protein profiling. For example, the World Health Organization (WHO) reported in July 2022 that genomic surveillance increased from 54% in March 2021 to 68% by January 2022, highlighting a significant rise in genomic practices. This growing adoption of genomics is fueling the protein microarray market.

Leading companies in the protein microarray sector are creating cutting-edge platforms using advanced technologies such as KREX technology. This technology facilitates high-throughput analysis of protein interactions, biomarker discovery, and disease diagnostics by ensuring that only correctly folded, full-length proteins are immobilized on the microarray surface while misfolded proteins are removed. For instance, in October 2023, Sengenics Corporation LLC, a US-based biotechnology company, introduced i-ome discovery. This advanced protein microarray platform enhances disease diagnosis and therapeutic interventions by analyzing over 1,800 autoantigens. By employing patented KREX technology and a sophisticated AI-based pipeline, it offers precise autoantibody detection, representing a notable advancement in the protein microarray market.

In March 2023, Spectrum Solutions, a US-based material technology company, acquired Alimetrix and Microarrays Inc. for an undisclosed sum. This acquisition is intended to enhance Spectrum's portfolio by integrating custom qualitative and quantitative assay development, along with advanced array-based products used in biological research. Alimetrix, a US-based company, specializes in advanced diagnostics, particularly for infectious diseases, while Microarrays Inc., also based in the US, focuses on providing protein microarray solutions.

Major companies operating in the protein microarray market are PerkinElmer Inc., Merck Group, Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Schott AG, Cepheid Inc., GenScript Biotech Corporation, Abcam plc, GVS S.p.A., Molecular Devices LLC, BioLegend Inc., Quanterix Corporation, Standard BioTools Inc., RayBiotech Life Inc., Creative Biolabs Inc., Sengenics Corporation LLC, PepperPrint GmbH, Quansys Biosciences Inc., Sciomics GmbH, Arrayit Corporation, LC Sciences, Full Moon BioSystems Inc.

North America was the largest region in the protein microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Protein microarray is a high-throughput technology that involves immobilizing numerous proteins onto a solid surface, enabling detailed analysis of protein profiles, biomarker discovery, and the study of disease mechanisms by detecting and quantifying protein interactions with other proteins or biomolecules.

The main types in the protein microarray market include lab-on-chips (microfluidics), protein chips, arrayers, integrated systems, and microarray systems. Lab-on-chips (microfluidics) are miniaturized devices that incorporate multiple lab functions onto a single chip, facilitating the manipulation and analysis of small fluid volumes. The technologies used encompass functional protein microarrays, analytical microarrays, and reverse phase protein microarrays, with applications in proteomics, diagnostics, antibody characterization, and protein functional analysis. The different end users include hospitals and clinics, research centers, academic institutions, and diagnostic centers.

The protein microarray market research report is one of a series of new reports that provides protein microarray market statistics, including protein microarray industry global market size, regional shares, competitors with an protein microarray market share, detailed protein microarray market segments, market trends, and opportunities, and any further data you may need to thrive in the protein microarray industry. This protein microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The protein microarray market consists of revenues earned by entities by providing services such as protein detection, quantification, and functional analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein microarray market includes sales of equipment, scanners, and slide washers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.